King Pharmaceuticals
American pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about King Pharmaceuticals?
Summarize this article for a 10 year old
King Pharmaceuticals, is a pharmaceutical company, a wholly owned subsidiary of Pfizer based in Bristol, Tennessee. Before being acquired by Pfizer, it was the world's 39th largest pharmaceutical company.[1][2] On October 12, 2010, King was acquired by Pfizer for $14.25 per share.[3] King produced a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals operated manufacturing facilities in Bristol, Tennessee; Rochester, Michigan; St. Louis, Missouri; St. Petersburg, Florida; and Middleton, Wisconsin. They employed approximately 2,700 people including a sales force of over 1,000 individuals.
Company type | Private |
---|---|
Industry | Pharmaceutical company, health care |
Founded | 1994 |
Headquarters | Bristol, Tennessee, USA |
Key people | Brian Markison, CEO Joseph Squicciarino, CFO Eric J. Bruce, CTO |
Products | Pharmaceuticals |
Revenue | $1.7 billion USD (2009)[1] |
$236 million USD (2009)[1] | |
$92 million USD (2009)[1] | |
Number of employees | 3,381 |
Website | www.kingpharm.com |
King Pharmaceuticals, Inc. was incorporated in the State of Tennessee in 1993. According to the King Pharmaceutcals, Inc. Form 10-K for the year ended December 31, 2007 filed with the U.S. Securities and Exchange Commission, the wholly owned subsidiaries of King Pharmaceuticals, Inc. are Monarch Pharmaceuticals, Inc.; King Pharmaceuticals Research and Development, Inc.; Meridian Medical Technologies, Inc.; Parkedale Pharmaceuticals, Inc.; King Pharmaceuticals Canada Inc.; and Monarch Pharmaceuticals Ireland Limited.[4]